Work

Phase III clinical trials of atezolizumab combined with chemotherapy in chemotherapy-naive patients with advanced NSCLC.

Year: 2016

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2016.34.15_suppl.tps9103

Authors: Vassiliki Papadimitrakopoulou, Federico Cappuzzo, Robert M. Jotte, Martin Reck, Tony Mok, Alan Sandler, Daniel Waterkamp, Shelley Coleman, Yasuo Sugitani, Mark A. Socinski

Institutions: The University of Texas MD Anderson Cancer Center, Ospedale di Livorno, Rocky Mountain Cancer Centers, German Center for Lung Research, LungenClinic Grosshansdorf, Chinese University of Hong Kong, Genentech, F. Hoffmann-La Roche AG, University of Pittsburgh

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2519019818

Cites:

Cited by: 4

Related to: 10